Staying AI-head of the game!

This blog post delves into the specific challenges posed by the complexities of interpreting biomedical language with a focus on Named Entity Recognition (NER), setting the stage for a deeper exploration of how Artificial Intelligence (AI) can help.

Manual curation and traditional NLP have limitations holding back our ability to fully leverage available data for drug development decision-making – this post dives into the promise of LLMs to overcome these limitations.

Perspectives from pharma leaders on how we enable AI models to produce high quality outputs to ensure data accessibility and usability.